Effect of a Synbiotic "Probiotical®/Bactecal® " in Asthma
Launched by UNIVERSITY OF LIEGE · Nov 10, 2017
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
Thirty percent of asthmatic patients are not well controlled even with an optimal treatment. There is then a need for new therapeutics allowing a better asthma control. Synbiotic (association of probiotics and prebiotics) have been shown to have anti-inflammatory properties as well as immunomodulatory activities. Moreover, synbiotic appeared to be very well tolerated and safe.
One hundred severe asthmatic patients (ACQ\> 1.5 and beclomethasone \> 200 µg per day) will receive "Probiotical ®/Bactecal®" (3 pills a day, content: Lactobacillus, Bifidobacterium et Streptococcus thermophilus, 18 ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • severe asthma (ACQ \>1.5 and treatment = minimum 200 µg beclomethasone) and stable treatment for at least 3 months.
- Exclusion Criteria:
- • treatment not stable
- • exacerbation state
- • infection
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liege, , Belgium
Patients applied
Trial Officials
Renaud Louis, Prof.
Principal Investigator
CHU-ULG
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials